BioNTech SE
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BioNTech SE and other ETFs, options, and stocks.About BNTX
BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators.
BNTX Key Statistics
BNTX News
Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...
Advertisement BioNTech's weak quarter and rising uncertainty BioNTech (BNTX) reported first quarter sales of €118.1 million and a net loss of €531.9 million,...
The stock’s decline comes amid a broader market rally, with major indices like the Nasdaq up by 1.19% and the S&P 500 gaining 0.72%. • BioNTech stock is under...
Analyst ratings
76%
of 21 ratingsMore BNTX News
(RTTNews) - Immunotherapy company Biopharmaceutical New Technologies or BioNTech SE (BNTX) reported Tuesday a net loss of 531.9 million euros or 2.10 euros per...
Reports Q1 EUR118.1M vs. EUR182.8M last year. “In the Q1, we made substantial progress in executing towards our oncology strategy, highlighted by data presentat...